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Physical Activity Is Prospectively Associated With
Adolescent Nonalcoholic Fatty Liver Disease
Emma L. Anderson, Abigail Fraser, Laura D. Howe, zMark P. Callaway,
§Naveed Sattar, jjChris Day, yKate Tilling, and Debbie A. Lawlor
ABSTRACT
Objectives: The aim of the present study was to assess whether objectively
measured physical activity at mean ages 12 and 14 years are prospectively
associated with ultrasound scan liver fat and stiffness (alanine aminotrans-
ferase, aspartate aminotransferase [AST], and g-glutamyl transferase
[GGT]) assessed at mean age 17.8 years.
Methods: Participants were from the Avon Longitudinal Study of Parents
and Children. Total physical activity (counts per minute) and minutes of
moderate to vigorous physical activity (MVPA) were measured using
ActiGraph accelerometers at mean ages 12 and 14 years.
Results: Greater total physical activity and MVPA at ages 12 and 14 years
were associated with lower odds of liver fat and lower GGT levels at mean
age 17.8 years, such as per 15-minute increase in daily MVPA at age
12 years, the confounder adjusted odds ratio of liver fat was 0.47 (95%
confidence interval [CI] 0.27–0.84). Associations attenuated after additional
adjustment for fat mass as a potential confounder (eg, per 15-minute increase
in daily MVPA at age 12 years, the odds ratio of liver fat attenuated to 0.65
[95% CI 0.35–1.21]) or a potential mediator (eg, per 15-minute increase in
daily MVPA at age 12 years the odds ratio of liver fat attenuated to 0.59
[95% CI 0.32–1.09]). Results did not further attenuate after additional
adjustment for insulin resistance. There was some evidence that greater total
physical activity and MVPA at age 12 years were associated with the higher
AST levels.
Conclusions: Adolescents who were more active in childhood have lower
odds of fatty liver and lower GGT levels. These findings are likely to be, at
least in part, explained by adiposity.
Key Words: Avon Longitudinal Study of Parents and Children, childhood,
exercise, fatty liver, physical activity
(JPGN 2016;62: 110–117)
G reater adiposity is an important risk factor for nonalcoholicfatty liver disease (NAFLD) (1). Consequently, lifestyle
modifications, including increasing physical activity levels with
the aim of reducing adiposity and limiting fatty liver infiltration and
necroinflammation, are recommended for both adult and child
patients with NAFLD (2,3). Physical activity could influence
What Is Known
 Cross-sectional evidence suggests physical activity is
inversely related to nonalcoholic fatty liver disease in
children/adolescents.
 Prospective associations have not been examined.
Thus, we are unable to establish whether lower
physical activity causes nonalcoholic fatty liver dis-
ease or nonalcoholic fatty liver disease causes lower
physical activity.
What Is New
 We provide evidence that adolescents who are more
active in late childhood have lower risk of ultrasound
scan fatty liver and lower g-glutamyl transferase
levels.
 These findings are likely to be, in part, explained by
adiposity.
 If replicated, our findings highlight the importance
of maintaining healthy levels of physical activity
throughout childhood for preventing nonalcoholic
fatty liver disease.
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NAFLD risk in several ways. Physical inactivity is associated with
greater total adiposity (4), which may increase the risk of fat
infiltration into hepatocytes by increasing free fatty acid (FFA)
influx from adipose tissue to the liver (5). Physical activity has been
shown to improve insulin sensitivity through decreasing fasting
insulin and increasing lean mass (6). In an insulin-resistant state, the
ability of insulin to suppress adipose tissue lipolysis is impaired,
leading to an increased efflux of FFA from adipose tissue and an
increased delivery of FFA to the liver (7). Physical activity may also
reduce levels of inflammatory markers that are involved in the
progression of steatosis to nonalcoholic steatohepatitis (8,9).
The existing evidence for an inverse association between
physical activity and NAFLD comes from cross-sectional studies
using questionnaires to assess physical activity (10–18), thus
potentially underestimating associations in comparison with objec-
tively measured physical activity (19). Furthermore, cross-sectional
studies cannot rule out reverse causation (ie, greater adiposity and
associated NAFLD causing people to be less active rather). Two
recent studies support this possibility (20,21). We are unaware of
any prospective studies assessing associations of physical activity
with NAFLD in children and/or adolescents. We aimed to assess
whether objectively measured physical activity at mean ages 12 and
14 years are associated with markers of NAFLD assessed at mean
age 17.8 years, and to determine whether any observed associations
are mediated through fat mass and insulin.
METHODS
Study Population
Avon Longitudinal Study of Parents and Children (ALSPAC)
is a prospective birth cohort from southwest England (full details in
online supplement, http://links.lww.com/MPG/A518) (22,23). The
study website contains details of all available data through a fully
searchable data dictionary (www.bris.ac.uk/alspac/researchers/
data-access/data-dictionary). Ethical approval for the study was
obtained from the ALSPAC Ethics and Law Committee and the
local research ethics committees. Briefly, ALSPAC recruited a
cohort of 14,541 pregnancies with expected delivery dates between
April 1, 1991, and December 31, 1992. A total of 13,678 singleton
live-born infants resulted from these pregnancies. The cohort has
been followed-up since birth, including repeat clinical assessment
from age 7 years to capture information on a range of characteristics
such as demographics, health-related behaviors, psychological and
social wellbeing, and health factors. A total of 5081 participants
attended the 17- to 18-year follow-up assessment at mean age 17.8
years, and of these, N¼ 3188 (62.7%) had data available for blood-
based indicators of liver function including alanine aminotransfer-
ase (ALT), aspartate aminotransferase (AST), and/or GGT. A liver
ultrasound scan substudy was undertaken on a randomly selected
subgroup of participants attending the 17- to 18-year follow-up
(N¼ 1887, 37%, Fig. 1) (24).
None of the participants had a known history of jaundice or
hepatitis, were taking medications or receiving treatment that would
indicate they had hepatic disease, or were taking medication known
to influence liver function. Participants’ alcohol consumptions were
assessed at mean ages 16.7 and 17.8 years using the Alcohol Use
Disorders Identification Test (AUDIT), which has been used to
validate the assessment of alcohol consumption in adolescents (25).
Participants answered 10 questions about their alcohol consump-
tion, and from their responses, a score between 0 and 20 was
derived. A score >16 is classified as harmful alcohol consumption.
Ten participants who completed the ultrasound scan examination
14,541 Pregnancies recruited
14,273 Singleton pregnancies
13,678 Singletons still alive at age 1 y
69 Lost to follow-up
195 Twin pregnancies
3 Triplets
1 Quadruplet
Additional 693 singleton
pregnancies recruited as
part as enrollement phases
II and III
3188 With available biomarker data from 17–18 y follow-up
5081 Attended the 17–18 y follow-up clinic
1887 Included in USS sub-study who completed USS examination
n = 1292 Partipants who have biomarker data available and
have a measure of physical activity at ages 12 and/or 14 y
ALT: n = 2612
AST: n = 2612
GGT: n = 2612
Eligible blood-based outcome sample*
Blood-based outcome data available
n = 1292 Partipants who have USS data available and
have a measure of physical activity at ages 12 and/or 14 y
USs lievr fat: n = 1292
USS liver stiffness: n = 1292
Eligible USS sample*
USS data available
FIGURE 1. Participant flow through the study.

Participants were excluded if they had nomeasure of physical activitymeasure at 12 or 14 years, or
they had harmful alcohol consumption. ALT¼alanine aminotransferase; AST¼aspartate aminotransferase; GGT¼g-glutamyl transferase;
USS¼ultrasound scan.
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and 25 participants with blood-based liver data who were classified
as harmful drinkers at both ages were excluded from this study.
Outcome Assessment
Ultrasound Scan Assessment of Liver Fat and
Stiffness
Details of ultrasound scan assessment in ALSPAC have
been published and are in the online supplement (http://links.lww.
com/MPG/A518) (24). Briefly, upper abdominal ultrasound scan
was completed by 1 of 4 trained sonographers using an Acuson
S2000 ultrasound scan system (Siemens, Erlangen, Germany) to
assess echogenicity and liver stiffness (our main indicator of liver
fibrosis). Echogenicity was assessed during deep inspiration and
recorded as present, absent, or uncertain according to established
protocols (26,27). Thus, the binary ultrasound scan liver fat
variable in this study is coded as present or absent. Acoustic
radiation force impulse (ARFI) imaging of the right lobe of the
liver was used to measure liver stiffness using standard protocols
(28,29). Levels of agreement in identifying echogenicity between
the 4 sonographers was high, both immediately after training and at
6-month intervals during data collection (absolute agreement of
98% or greater).
Assessment of Blood-Based Liver Outcomes
Participants were instructed to fast overnight or for a mini-
mum of 6 hours. Fasting blood samples were immediately spun and
frozen at 808C. Measurements were assayed within 3 to 9 months
after samples were taken, with no previous freeze-thaw cycles.
ALT, GGT, and AST were measured by automated analyzers with
enzymatic methods. All of the inter coefficients and intracoeffi-
cients of variation for these blood-based assays were <5%.
Assessment of Physical Activity
Detailed methods of physical activity assessment have been
described (30) and are in the online supplement (http://links.lww.-
com/MPG/A518). Briefly, physical activity was objectively
assessed at mean ages 12 and 14 years with a uniaxial ActiGraph
accelerometer (AM7164 2.2; ActiGraph LLC, Fort Walton Beach,
FL; http://www.theactigraph.com) for 7 days. The participants
recorded the times at which the ActiGraph was worn and any times
that they swam or cycled each day. Total physical activity (average
counts per minute) during the valid measurement period and
average time spent in moderate to vigorous physical activity
(MVPA) in minutes per valid day were derived. The cutoff point
used to define MVPAwas a CPM>3600 (31). Counts are a result of
summing postfiltered accelerometer values (raw data at 30 Hz) into
epoch ‘‘chunks.’’ The value of the counts will vary based on the
frequency and intensity of the raw acceleration. The filtering
process by which counts are produced is proprietary to ActiGraph.
Covariables
The assessment of all of the covariables is described in detail
in the online supplement (http://links.lww.com/MPG/A518). The
following were considered potential confounders: sex, maternal age
at delivery, parity, maternal education, head of household, social
class, maternal body mass index (BMI), ethnicity, energy intake at
age 11 years, pubertal status at age 11 years, age at physical activity
assessments and liver outcome assessment, and length of time
accelerometer was worn (in minutes). Given that adiposity is known
to be causally related to physical activity (20), and could possibly be
causally related to NAFLD, we considered adiposity (measured by
dual x-ray absorptiometry [DXA] total body fat mass) as a potential
confounder. We also considered adiposity and insulin resistance
(assessed by the homeostatic model assessment of insulin resistance
[HOMA-IR]) at the time of liver outcome assessment as potential
mediators (ie, potentially being on the causal pathway between
physical activity and NAFLD).
Eligibility Criteria
For analysis of ultrasound scan liver outcomes, eligible partici-
pants had to have valid data for ultrasound scan liver fat and liver
stiffness, and a measure of physical activity at mean age 12 and/or
14 years (n¼ 1292). For analyses of blood-based liver outcomes,
eligible participants had to have data for ALT, AST, and GGT and a
measure of physical activity at mean age 12 and/or 14 years
(n¼ 2612). As described above, participants’ alcohol consumption
was assessed using AUDIT (25). No eligible participants were
classified as having harmful levels of alcohol consumption.
Statistical Analysis
All the analyses were conducted in Stata (StataCorp, College
Station, TX). Total physical activity was divided by 100 and MVPA
by 15; these values were chosen because they represent realistic
intervention targets (32). ALT, AST, GGT, and liver stiffness were
positively skewed, and their natural logged values were used in all
of the linear regression analyses. Coefficients from regression
models including these logged variables as outcomes were back
transformed. Associations of total physical activity and MVPAwith
the binary ultrasound scan liver fat variable were assessed with
logistic regression.
Associations of total physical activity and MVPA with liver
outcomes were examined using the following regression models:
unadjusted; adjusted for, sex, maternal age at delivery, parity,
maternal education, head of household, social class, maternal
BMI, ethnicity, energy intake at age 11 years, pubertal status at
age 11 years, age at physical activity and liver outcome assessments,
and the length of time the accelerometer was worn; same as model 2
but additionally adjusted for DXA-determined fat mass, height, and
height2 at the time physical activity was assessed as a potential
confounder; same as model 2 but additionally adjusted for DXA-
determined fat mass, height, and height2 at the time all of the liver
outcomes were assessed as a potential mediator; same as model 4
but additionally adjusted for HOMA-IR at the time all the liver
outcomes were assessed as another potential mediator. The
inclusion of height and height-squared as covariables in all of
the analyses including fat mass is to ensure adjustment for greater
relative adiposity, rather than greater fat mass as a result of greater
height. Likelihood ratio tests were used to check for sex interactions
in all of the models.
Dealing With Missing Data and Additional
Analyses
Of the 1292 eligible participants with ultrasound scan data
and a physical activity measure at ages 12 and/or 14 years, 7% of the
participants were missing data for one of the physical activity
measures at either age 12 or 14 years. Of the 2612 eligible
participants with blood-based liver data and a physical activity
measure at ages 12 and/or 14 years, 30% of the participants were
missing data for one of the physical activity measures at either age
12 or 14 years. There was also missing data for potential con-
founders. Web Tables A and B, http://links.lww.com/MPG/A518,
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show the percentage of imputed data for each variable. To minimize
selection bias and increase efficiency, multivariate multiple impu-
tation was used to impute missing data for eligible participants. Full
details of this procedure are in the online supplement (http://
links.lww.com/MPG/A518). Details of a series of sensitivity
analyses, conducted to verify model assumptions and to test the
robustness of our findings, are also provided in the online supple-
ment (http://links.lww.com/MPG/A518).
RESULTS
Characteristics of the ultrasound scan study participants stra-
tified by ultrasound scan–identified liver fat are described in Table 1.
The sample consisted of 96% white participants. There was no
evidence that associations of total physical activity and MVPA at
ages 12 and 14 years with the liver outcomes differed between boys
and girls (all interaction P values>0.05). Thus, results are presented
with sexes combined, and sex is adjusted for in all the models.
Prevalence of ultrasound scan fatty liver was 2.7% in boys
(n¼ 14/524) and 2.1% in girls (n¼ 16/768). ALT was elevated
(>40 U/L) in 4.2% of the boys (n¼ 53/1249) and 1.8% of the girls
(n¼ 25/1363). Variable distributions were similar among the
imputed and observed data sets (Web Tables C and D, http://
links.lww.com/MPG/A518).
Associations of Total Physical Activity and
MVPA at Mean Ages 12 and 14 Years
With the Ultrasound Scan Liver Outcomes
at Mean Age 17.8 Years
Confounder and mediator-adjusted associations (ie, models
2–5) of total physical activity and MVPA with the ultrasound scan
liver outcomes are presented in Table 2. Unadjusted results are in
Web Table E, http://links.lww.com/MPG/A518. There was evidence
of an inverse association of total physical activity and MVPA at
ages 12 and 14 years with the risk of ultrasound scan liver fat in the
unadjusted model (model 1, Web Table E, http://links.lww.com/
MPG/A518) and after adjusting for potential confounders (model 2,
Table 2). Associations attenuated toward the null after additional
adjustment for fat mass at the time of physical activity assessment
as a potential confounder (model 3, Table 2), and to a lesser extent
after adjustment for fat mass at the time of liver outcome assessment
as a potential mediator (model 4, Table 2). Associations did not
further attenuate upon additional adjustment of HOMA-IR as a
potential mediator (model 5, Table 2). Coefficient magnitudes were
greater at age 12 years compared with age 14 years. There were no
associations of total physical activity and MVPA with liver stiffness
(Table 2).
Associations of Total Physical Activity and
MVPA at Ages 12 and 14 Years With the
Blood-Based Liver Outcomes at Mean
Age 17.8 Years
Confounder and mediator-adjusted associations (ie, models
2–5) of total physical activity and MVPA with the blood-based
liver outcomes are presented in Table 3. Unadjusted results are in
Web Table F, http://links.lww.com/MPG/A518. After adjusting for
potential confounders (model 2, Table 3), there was no evidence of
associations of total physical activity or MVPA at 12 or 14 years
with ALT. There was evidence for small positive associations of
total physical activity and MVPA at age 12 years with AST in all the
models. There was also evidence of positive associations of total
physical activity and MVPA at age 14 years with AST in the
unadjusted model (model 1, Web Table F, http://links.lww.com/
MPG/A518), and the point estimate did not change after adjustment
for potential confounders and mediators (models 2–5, Table 3).
After adjusting for potential confounders (model 2, Table 3), there
was strong evidence of small inverse associations of total physical
activity and MVPA at age 12 years with GGT. Point estimates
attenuated toward the null after adjusting for fat mass as a
potential confounder (model 3, Table 3) or a potential mediator
(model 4, Table 3), and associations did not change after additional
adjustment for HOMA-IR as a potential mediator (model 5,
Table 3).
Additional Analyses
Results were similar when restricted to participants with
complete data for all the variables except confidence intervals were
much wider, likely because of the large reduction in sample size
(ultrasound scan data set reduced from n¼ 1292 in the imputed data
to n¼ 506 in the complete case, and the biomarker data set reduced
from n¼ 2612 to n¼ 1117, Web Tables G and H, http://links.lww.-
com/MPG/A518). The results were also similar when multiple
imputation models were restricted to participants with data for
physical activity at age 12 years (Web Tables I and J, http://
links.lww.com/MPG/A518) and participants with data for physical
activity at age 14 (Web Tables K and L, http://links.lww.com/MPG/
A518). There was no evidence that the odds of missing physical
activity data at age 14 years were associated with physical activity
at age 12 years, adjusted for all of the variables included in our
multiple imputation models (Web Table M, http://links.lww.com/
MPG/A518). Results were similar after additional adjustment for
AUDIT scores in the year before assessing liver outcomes (Web
Tables N and O, http://links.lww.com/MPG/A518).
DISCUSSION
In this study, we assessed prospective associations of
objectively measured physical activity at mean ages 12 and
14 years with measures of liver fat at mean age 17.8 years.
Greater total physical activity and MVPA, at both ages 12 and
14 years, were prospectively associated with lower risk of
ultrasound scan liver fat. These associations with ultrasound
scan liver fat attenuated toward the null after adjusting for fat
mass as a potential confounder, and to a lesser extent with
adjustment for fat mass as a potential mediator. Greater total
physical activity and MVPA at age 12 years were also prospec-
tively associated with lower levels of GGT, which is associated
with cardiovascular disease (33), diabetes (34), and insulin
resistance (35). These associations attenuated toward null after
adjusting for fat mass as a potential confounder and as a potential
mediator. Associations did not further attenuate upon additional
(to fat mass) adjustment of HOMA-IR as a potential mediator.
Thus, the effect of physical activity on the liver outcomes may
operate through adiposity mediating the relation of physical
activity to NAFLD, and/or through greater adiposity leading
to reduced physical activity (19,20) and greater NAFLD risk,
thus confounding the association, or a combination of both.
Cross-sectional studies have reported inverse associations
with ultrasound scan liver fat (12,14,16) and biomarkers, including
ALT (11–13) and GGT (11), with some of these studies reporting
associations to be independent of adiposity measures (13,16). A
small number of studies show no association of physical activity
with ultrasound scan or biomarkers of liver fat in children, irre-
spective of adjustment for adiposity (10,17,18). Randomized con-
trolled trials show beneficial effects of lifestyle interventions on
markers of liver fat, including on levels of GGT and ALT providing
JPGN  Volume 62, Number 1, January 2016 Physical Activity, Adolescent Nonalcoholic Fatty Liver Disease
www.jpgn.org 113
 Copyright © ESPGHAL and NASPGHAN. All rights reserved.
TABLE 1. Characteristics of participants included in the ultrasound scan study (N¼1292)
Participants without ultrasound scan
liver fat (n¼ 1262)
Participants with ultrasound scan liver
fat (n¼ 30)
n with
available data Distribution
n with
available data Distribution
P for
difference
Median liver stiffness (IQR) 1262 1.18 (1.07, 1.31) 30 1.41 (1.23, 1.98) <0.001
Median ALT, U/L (IQR) 866 15.5 (12.4, 19.6) 16 20.65 (17.1, 42.7) <0.001
Median AST, U/L (IQR) 866 19.7 (16.9, 23.3) 16 21.6 18.15 31.75
21.6 18.15 31.75
21.6 (18.15, 31.75) 0.06
Median GGT, U/L (IQR) 865 16.0 (13.0, 20.0) 16 28.5 (17.0, 41.0) <0.01
Median CPM at age 12 y (IQR) 1180 564 (464, 694) 28 481 (441, 613) 0.03
Median CPM at age 14 y (IQR) 882 500 (398, 650) 21 420 (397, 524) 0.08
Median MVPA at age 12 y, minutes per day (IQR) 1180 18.4 (11.07, 29.83) 28 14.51 (7.75, 18.57) 0.02
Median MVPA at age 14 y, minutes per day (IQR) 882 19.15 (9.80, 32.0) 21 15.67 (6.0, 22.0) 0.08
Mean maternal age, y (SD) 1220 29.58 (26.58, 32.83) 27 30 (27.58, 33.42) 0.60
Median maternal BMI, kg/m2 (IQR) 1109 22.18 (20.47, 24.38) 26 23.50 (21.33, 26.49) <0.01
Median predicted energy intake at age 12 y, kcal (IQR) 1258 2011 (1911, 2156) 30 2051 (1963, 2234) 0.11
Median fat mass at mean age 12 y, kg (IQR) 1208 10.1 (6.8, 15.0) 29 19.5 (16.1, 27.5) <0.001
Median fat mass at mean age 14 y, kg (IQR) 1115 12.2 (7.9, 18.1) 26 26.9 (18.1, 30.4) <0.001
Median fat mass at mean age 17.8 y, kg (IQR) 1224 16.6 (11.3, 23.3) 29 36.9 (28.9, 46.6) <0.001
Median HOMA-IR at mean age 17.8 y, kg (IQR) 865 1.49 (1.08, 2.09) 16 3.24 (2.24, 4.23) <0.001
Mean height at mean age 17.8 y, cm (SD) 1234 170.57 (9.40) 30 171.81 (8.98) 0.48
Median age at outcome assessment, mo (IQR) 1262 213 (212, 216) 30 214 (213, 217) 0.16
BMI category 1233 30
Obese 5.52 53.33 <0.001
Overweight 16.30 30.00
Normal weight 73.15 10.00
Underweight 5.03 6.67
Sex 1262 30
Males 40.41 46.67 0.49
Females 59.59 53.33
Parity 1165 26
0 49.61 34.62 0.30
1 34.59 42.31
2þ 15.79 23.08
Head of household, social class
Manual 1134 11.99 24 16.67 0.49
Nonmanual 88.01 83.33
Mothers’ education 1148 24
O level 51.39 41.67 0.55
A level 27.96 37.50
Degree or above 20.64 20.83
Tanner stage for pubic hair development at age 11 y 946 21
Prepubertal 62.58 76.19 0.65
Pubertal/postpubertal 37.42 23.81
Alcohol consumption in the year before
outcome assessment
1166 29
Normal 63.72 62.07 0.95
Hazardous 31.73 31.03
Harmful 4.55 6.90
When the median and IQR is displayed, a Mann-Whitney U test was used to check for differences between those with and without ultrasound scan liver fat.
When the mean and SD are displayed, a 2-tailed t test was used to check for differences between those with and without ultrasound scan liver fat. The ‘N with
available data’ columns relate to the number of participants included in the imputation data sets, who had data for each of the variables included in our analysis.
The highest pubertal stage was established by taking the highest Tanner rating for either breast development or pubic hair. If there were missing data for breast
development, pubic hair ratings were used when available and vice versa. BMI was categorized as follows: underweight (BMI 18), normal weight (BMI>18
to25), overweight (BMI>25 to30), and obese (BMI> 30). ALT¼ alanine aminotransferase; AST¼ aspartate aminotransferase; BMI¼ body mass index;
CPM¼ counts per minute; GGT¼g-glutamyl transferase; HOMA-IR¼ homeostatic model assessment of insulin resistance; IQR¼ interquartile range;
MVPA¼moderate to vigorous physical activity; SD¼ standard deviation.
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some support for a possible causal effect (3,36–38). Those trials,
however, have all combined physical activity interventions with
nutrition programs or antioxidant therapy; thus, it is impossible to
assess the relative contribution of physical activity to the observed
improvements in NAFLD parameters.
We found no associations of physical activity with ALT in
our study. As noted above, in cross-sectional studies of children,
greater levels of physical activity have been related to lower ALT
levels. Given the prospective association we observed with ultra-
sound scan fatty liver, which is a more direct measure of liver fat,
the lack of association with ALT in our study is difficult to explain
but could reflect random sampling variation. We also found that
childhood physical activity was not associated with ultrasound
scan–assessed liver stiffness. This may reflect earlier physical
activity reducing the risk of fat in the liver but not being sufficient
to influence fibrosis, if it has become established. Further exam-
ination in prospective studies with relevant data is important before
making conclusions about these findings.
We found that children with greater levels of physical
activity in childhood had higher AST levels in adolescence. AST
is abundant in muscle cells, and studies have reported greater
physical activity, particularly vigorous activity, to be associated
with higher circulating levels possibly because of muscle cell
breakdown (39–41). Consistent with this and our findings, a recent
cross-sectional study found that adolescents achieving daily recom-
mended time spent in objectively measured MVPA (compared with
those not achieving this recommendation) had lower GGT and ALT
but higher AST (42).
Strengths and Limitations
To our knowledge, this is the first study to prospectively
assess associations of objectively measured physical activity in
childhood with the risk of NAFLD in adolescence. Although power
for the binary outcome of ultrasound scan–measured liver fat was
limited because of the small number of cases, we looked at a range
of related outcomes including ALT. A recent meta-analysis includ-
ing 49 different studies found ultrasound scan to be reliable and
accurate for the detection of moderate-severe hepatic steatosis
compared with liver histology (43) but less able to distinguish
mild fat infiltration. This means our NAFLD cases are likely to
reflect the moderate/severe end of the disease spectrum, and the
associations observed between physical activity and ultrasound
scan liver fat may be underestimated. The ARFI measure of liver
stiffness has been validated in a small number of clinical studies
(44,45). Although there was a greater proportion of missing data for
the physical activity measure at age 14 years compared with at age
12, results were similar for the complete case analyses and when
restricting multiple imputation analyses to those with a measure of
physical activity at ages 12 and 14 years (ie, only imputing missing
confounder data). Furthermore, we found no evidence that miss-
ingness at age 14 years was associated with physical activity at age
TABLE 2. Associations of physical activity measures at ages 12 and 14 years with USS liver outcomes at mean age 17.8 years in the imputed data
(n¼1292)
Adjusted for
confounders

Adjusted for confounders
plus fat mass, height, and
height2 at the time physical
activity was assessedy
Adjusted for confounders
plus fat mass, height, and
height2 at the time of liver
outcome assessmentz
Adjusted for confounders
plus fat mass, height, height2,
and HOMA-IR at the time of
liver outcome assessment§
USS liver fat
OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P
Total physical activity
12 y 0.71 (0.54–0.94) 0.02 0.82 (0.60–1.12) 0.22 0.76 (0.56–1.03) 0.08 0.73 (0.52–1.01) 0.06
14 y 0.77 (0.58–1.02) 0.07 0.84 (0.61–1.15) 0.28 0.82 (0.60–1.10) 0.19 0.79 (0.57–1.08) 0.14
MVPA
12 y 0.47 (0.27–0.84) 0.01 0.65 (0.35–1.21) 0.17 0.59 (0.32–1.09) 0.09 0.53 (0.27–1.03) 0.06
14 y 0.63 (0.39–1.04) 0.07 0.72 (0.42–1.26) 0.26 0.70 (0.41–1.19) 0.19 0.67 (0.39–1.13) 0.13
USS liver stiffness
% Change (95% CI) P % Change (95% CI) P % Change (95% CI) P % Change (95% CI) P
Total physical activity
12 y 0 (1 to 1) 0.96 0 (0–1) 0.35 0 (0–1) 0.67 0 (0–1) 0.66
14 y 0 (1 to 0) 0.21 0 (1 to 0) 0.44 0 (1 to 0) 0.27 0 (1 to 0) 0.26
MVPA
12 y 0 (1 to 1) 0.83 1 (1 to 2) 0.36 0 (1 to 1) 0.72 0 (1 to 1) 0.72
14 y 1 (2 to 0) 0.23 0 (1 to 1) 0.44 1 (2 to 0) 0.27 1 (2 to 0) 0.26
Coefficients are per increase of 100 CPM (total physical activity) or per 15-minute increase in MVPA. Unadjusted results (model 1) are provided in Table E
of the online supplement (http://links.lww.com/MPG/A518). BMI¼ body mass index; CI¼ confidence interval; CPM¼ counts per minute; HOMA-
IR¼ homeostatic model assessment of insulin resistance; MVPA¼moderate to vigorous physical activity; OR¼ odds ratio; USS¼ ultrasound scan.
Model 2: adjusted for mother’s age at delivery, parity, sex, ethnicity, mother’s education, head of household, social class, mother’s BMI, energy intake at age
11 years, pubertal status at age 11 years, age at physical activity assessment, length of time accelerometer was worn (in minutes), and age at the time of liver
assessment.
yModel 3: adjusted for all of the potential confounders listed above plus fat mass, height, and height2 at the time physical activity was assessed.
zModel 4: adjusted for all of the potential confounders listed above plus fat mass, height, and height2 at the time of liver outcome assessment.
§Model 5: adjusted for all potential confounders listed above plus fat mass, height, height2 and HOMA-IR at the time of liver outcome assessment.
JPGN  Volume 62, Number 1, January 2016 Physical Activity, Adolescent Nonalcoholic Fatty Liver Disease
www.jpgn.org 115
 Copyright © ESPGHAL and NASPGHAN. All rights reserved.
12 years. Together, these findings suggest that missing data is
unlikely to importantly introduce bias in these associations.
CONCLUSIONS
We have shown that adolescents who were more active in
late childhood have lower fat mass in adolescence, which in turn is
related to the lower risk of ultrasound scan fatty liver and lower
levels of GGT. If our findings are replicated, they highlight the
importance of maintaining healthy levels of physical activity
through childhood to prevent the risk of subsequent NAFLD.
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Physical Activity Is Prospectively Associated
With Adolescent Nonalcoholic Fatty Liver
Disease: Erratum
I n the article that appeared on page 110 in the January 2016 issue of Journal of Pediatric Gastroenterology & Nutrition, the copyright lineshould have read: Copyright @ 2015 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Society
for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and
Nutrition. All rights reserved. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This article has been corrected online.
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